Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Nathan Acott"'
Autor:
Duminda Subasinghe, Nathan Acott, Pasyodun Koralage Buddhika Mahesh, Sivasuriya Sivaganesh, Sithum Munasinghe, Mariyan Priyanthi Kumarasinghe, Dharmabandu Nandaveva Samarasekera, Menaka Dilani Samarawickrema Lokuhetty
Publikováno v:
Journal of International Medical Research, Vol 51 (2023)
Objective Positive human epidermal growth factor 2 (HER2) expression and its predictive clinicopathological features remain unclear in Sri Lankan gastric cancer (GC) patients. Here, we aimed to determine GC HER2 status predictors by analyzing associa
Externí odkaz:
https://doaj.org/article/6fbdff7415b94abca86685955c0dc910
Publikováno v:
Cytopathology. 33:84-92
OBJECTIVE To assess the utility of BRCA-1 associated protein 1 (BAP1) immunohistochemistry (IHC) for the diagnosis of malignant pleural mesothelioma (MPM) in pleural fluid samples with atypical cytology. METHODS Pleural fluid samples received between
Autor:
Benjamin A. Wood, Dugald McCallum, Jean Iacobelli, Nathan Acott, Nathan T. Harvey, Chris van Vliet, Tamazin Leecy, Nima Mesbah Ardakani, Joanne Peverall
Publikováno v:
The American Journal of Dermatopathology. 43:913-920
Preferentially expressed antigen in melanoma (PRAME) is a tumor-associated repressor of retinoic acid signaling which is expressed in melanoma and has emerged as a potential biomarker for malignant behavior in melanocytic neoplasms. Although ancillar
Autor:
Amber Louw, Chris van Vliet, Joanne Peverall, Shane Colkers, Nathan Acott, Jenette Creaney, Y. C. Gary Lee, Siaw Ming Chai
Publikováno v:
Cancer cytopathologyReferences. 130(5)
The concept of mesothelioma in situ has been revisited and is a new World Health Organization diagnostic entity. The definition centers on ancillary techniques used in pleural mesothelioma (PM) assessment. At the authors' institution, most PM diagnos
Autor:
Marian Priyanthi Kumarasinghe, Sivasuriya Sivaganesh, Duminda Subasinghe, Dharmabandu Nandadeva Samarasekera, Ananthi Samarasekera, Nathan Acott, Pkb Mahesh, M. D. S. Lokuhetty
Background: Accurate HER2 status is crucial for gastric adenocarcinoma (GC) patient selection for antiHER2 therapy. It is assessed immunohistochemically (IHC) for protein expression, and by silver in-situ hybridization (SISH) for gene copy number. Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::de87dc23ec53dd9702d85c6a75f5c6aa
https://doi.org/10.21203/rs.3.rs-298497/v1
https://doi.org/10.21203/rs.3.rs-298497/v1
Autor:
Sivasuriya Sivaganesh, Duminda Subasinghe, Mariyan Priyanthi Kumarasinghe, Pasyodun Koralage Buddika Mahesh, M. D. S. Lokuhetty, Dharmabandhu N. Samarasekera, Nathan Acott, Ananthi Samarasinghee
Publikováno v:
Posters.
Publikováno v:
Histopathology. 72:626-633
Aims Micropapillary carcinomas, or carcinomas with a micropapillary component, are well recognised in the breast and other anatomical sites. However, they have seldom been described in the cervix. In this article, we present a clinicopathological ana
Autor:
Christopher W. Toon, Spiro Raftopoulos, Bob Mirzai, Benjamin M. Allanson, Marian Priyanthi Kumarasinghe, Connull Leslie, Nathan Acott
Publikováno v:
Pathology. 51(3)
There is increasing interest in p53 immunohistochemistry as an adjunct to haematoxylin and eosin (HE) assessment for dysplasia in oesophageal Barrett's mucosa; however, published information on the patterns of staining remains scant. Here, we present
Publikováno v:
Gastrointestinal endoscopy. 90(1)
Human epidermal growth factor receptor 2 (HER2) status determines gastric/gastroesophageal junction (GEJ) adenocarcinomas that benefit from targeted therapy; hence, HER2 testing has become a routine practice. Accurate HER2 testing is fundamental to s
Publikováno v:
Methods in molecular biology (Clifton, N.J.). 1756
HER2 positivity is based on the fundamental principle of amplification of the human epidermal growth factor receptor 2 (HER2) gene resulting in overexpression of the protein products . Arising from that a "HER2-positive cancer" is one that shows HER2